Baird Defends St. Jude (STJ) Following Lowered Guidance; Upgrades to Outperform
Tweet Send to a Friend
An analyst at Robert W. Baird is out in defense of St. Jude Medical (NYSE: STJ) today following news ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
